GAMMA Investing LLC increased its stake in Stryker Corporation by 16.4%, bringing its total investment to $2.08 million.

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Stryker (SYK – Research Report), with a price target of $450.00. The companys ...

Stryker has appointed Mike Carlin to lead its digital and robotics business. Spencer Stiles, Stryker’s group president of ...

Stryker has received 510(k) clearance from the FDA for its Incompass Total Ankle System, a next-generation implant targeting ...

The MedTech segment accounts for around 36% of J&J’s total revenues. Sales in the MedTech segment rose 4.1% on an operational ...

Suryakumar Yadav surprised fans with a health update on Wednesday, June 25. From a Munich hospital bed, SYK shared an ...

This was the stock's fourth consecutive day of gains.

Stryker has secured FDA clearance for its Incompass total ankle system to treat patients whose ankle joints have been damaged by severe rheumatoid, post-traumatic or degenerative arthritis. The ...

Stryker (NYSE:SYK) recently received FDA clearance for its Incompass® Total Ankle System, a significant product innovation that highlights the company's commitment to advancing patient care. Over the ...

StrykerSYK saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 64 to 71. Please watch the video at Investors.com - Stock Market Exposure: How To Make ...

According to Benzinga Pro, Stryker's peer group average for short interest as a percentage of float is 5.30%, which means the ...